40 Medical Colleges Lose Recognition For Non-Compliance, 100 Under Lens

New Delhi (ANI): About 40 medical colleges have lost recognition over the last one to two months period for not meeting the standards set by National Medical Commission (NMC) in India, said official sources.

Further, according to the official sources, a further 100 medical colleges in Puducherry, Gujarat, Assam, Andhra Pradesh and Tamil Nadu are also likely to lose recognition for not complying with the NMC’s standards.

One of these medical colleges in Arunachal Pradesh, which is more than a century old, also lost recognition as part of the crackdown by the NMC, sources said.

The action was taken on account of these institutions not complying with norms as well as lapses pertaining to faculty and security (CCTV) cameras, official sources said.

Further, some doctors have also written to the Union Health Ministry on the action taken by the NMC citing the non-compliance of standards are other lapses by these institutions.

In their letter, the doctors voiced fears that the action could affect their careers and also result in a loss of credibility.

According to government data, the number of medical colleges in the country has increased from 387 in 2014 to 654 presently, almost double.

The number of MBBS seats has also seen a 94 per cent increase.
  • Related Posts

    Diabetic drug metformin found to act on brain

    NEW DELHI:  Cheap, effective and widely trusted, metformin has long been the first choice for treating type 2 diabetes. Now, scientists say the drug works in a way few had…

    Hetero debuts semaglutide generic in emerging markets

    New Delhi: Hyderabad-based drugmaker Hetero has announced the launch of its generic semaglutide portfolio in emerging international markets. In a phased global push, the company plans to roll out its…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Diabetic drug metformin found to act on brain

    Diabetic drug metformin found to act on brain

    Hetero debuts semaglutide generic in emerging markets

    Hetero debuts semaglutide generic in emerging markets

    LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

    LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

    Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

    Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

    Stem cell therapy for autism illegal: NMC advisory

    Stem cell therapy for autism illegal: NMC advisory

    India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework

    India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework